How to move towards precision I-O? Innovation in biomarker R&D

IMMUNO-ONCOLOGY INSIGHTS

How to move towards precision I-O? Innovation in biomarker R&D

July 2022
How to move towards precision I-O? Innovation in biomarker R&D

Interview

Old data, new tools: leveraging routinely acquired patient data to address current challenges in I–O

Old data, new tools: leveraging routinely acquired patient data to address current challenges in I–O

Dr Anant Madabhushi
3 August 2022
Read
Taking the initiative to advance precision medicine: a perspective from Norway

Taking the initiative to advance precision medicine: a perspective from Norway

Kjetil Taskén
17 July 2022
Read

FastFacts

Leveraging oncology gene expression signatures to accelerate research

Leveraging oncology gene expression signatures to accelerate research

Sarah Church
2 July 2022
Read